Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Acta Pharmaceutica is Scopus-indexed (Q2, CiteScore 3.2), WoS SCIE, DOAJ. Published by Hrvatsko Farmaceutsko Drustvo.
Checked against the index lists dated .
ISSN 1330-0075Verify ISSN ↗1846-9558Verify ISSN ↗
Publisher: Hrvatsko Farmaceutsko Drustvo
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 93 / 191 | 51st | Q2 |
| Pharmacology | 208 / 328 | 36th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1992–present, best quartile Q2, CiteScore 3.2.
Acta Pharmaceutica is Q2 in Pharmaceutical Science (rank 93 of 191) and Q3 in Pharmacology (rank 208 of 328), by CiteScore 2025.
Acta Pharmaceutica is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.464, quartile Q2, with an H-index of 70.
The publisher lists an article processing charge of about US$970 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Acta Pharmaceutica is published by Hrvatsko Farmaceutsko Drustvo. Its print ISSN is 1330-0075 and its online ISSN is 1846-9558.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Acta Pharmaceutica has an h-index of 62 and a 2-year mean of 2.51 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #72 of 177 Scopus journals in Pharmaceutical Science.
Acta Pharmaceutica published 39 papers in 2025; its busiest recent year was 2020 with 62. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from Croatia (22.3%), China (22.3%) and Slovenia (18.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.